April 27, 2024 Alphabet and Microsoft’s AI Investments Yield Strong Returns
April 26, 2024 Top 10 High Dividend Yield Stocks
Tesla Q1: Model 2 Could Be Their Model T
Tesla Is An AI Company That The Market Won’t Reward For Now
Amazon: The Margin Train Is Gaining Speed
April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?
April 12, 2024 Improve Your Financial Status: A How-To Guide
April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade
March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5
Esperion Therapeutics, Inc. (ESPR) Stock Forecast for 2027. Espr Shares Prediction
Updated: April 24, 2024 (11:15)
Sector: HealthcareThe share price of Esperion Therapeutics, Inc. (ESPR) now
50/200 Day Moving Average: $2.446 / $1.78
This figure corresponds to the Average Price over the previous 50/200 days. For Esperion Therapeutics stocks, the 50-day moving average is the resistance level today.
For Esperion Therapeutics stocks, the 200-day moving average is the resistance level today.
Are you interested in Esperion Therapeutics, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Esperion Therapeutics stock price in 2027. How much will one Esperion Therapeutics share be worth in 2027? Is it worth taking profit / loss on ESPR stock now or waiting? What are analysts' forecasts for Esperion Therapeutics stock?
We forecast Esperion Therapeutics stock performance using neural networks based on historical data on ESPR stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. This corporation stock prediction results are shown below and presented as a graph, table and text information.
Esperion Therapeutics, Inc. stock forecasts are adjusted once a day based on the closing price of the previous trading day.
The minimum target price for Esperion Therapeutics analysts is $7.41. Today 200 Day Moving Average is the support level (1.78 $). 50 Day Moving Average is the support level (2.446 $).
Historical and forecast chart of Esperion Therapeutics, Inc. stock
The chart below shows the historical price of Esperion Therapeutics stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the ESPR stock price can be found in the table below.
Esperion Therapeutics (ESPR) Forecast for 2027
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 4.89 | 4.20 | 5.77 | 27.20 % |
| Feb | 5.37 | 4.92 | 6.31 | 21.98 % |
| Mar | 6.05 | 5.65 | 6.61 | 14.55 % |
| Apr | 6.74 | 5.85 | 7.57 | 22.71 % |
| May | 6.19 | 4.95 | 6.64 | 25.47 % |
| Jun | 7.57 | 6.05 | 8.91 | 32.12 % |
| Jul | 8.79 | 7.39 | 10.35 | 28.55 % |
| Aug | 8.24 | 7.23 | 9.60 | 24.72 % |
| Sep | 7.42 | 6.27 | 7.87 | 20.38 % |
| Oct | 6.91 | 5.56 | 7.99 | 30.36 % |
| Nov | 7.30 | 6.65 | 8.23 | 19.18 % |
| Dec | 8.20 | 6.75 | 9.06 | 25.52 % |
Esperion Therapeutics information and performance
3891 RANCHERO DRIVE, SUITE 150, ANN ARBOR, MI, US
Market capitalization of the Esperion Therapeutics, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of ESPR shares in the company outstanding by the market price of one share.
EBITDA of Esperion Therapeutics is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
Esperion Therapeutics price target for 2027 by month
Target values for the price of one Esperion Therapeutics share for Jan 2027.
In Jan, the Positive dynamics for Esperion Therapeutics, Inc. shares will prevail with possible monthly volatility of 27.203% volatility is expected.
Pessimistic target level: 4.20
Optimistic target level: 5.77
Target values for the price of one Esperion Therapeutics share for Feb 2027.
In Feb, the Positive dynamics for Esperion Therapeutics, Inc. shares will prevail with possible monthly volatility of 21.976% volatility is expected.
Pessimistic target level: 4.92
Optimistic target level: 6.31
Target values for the price of one Esperion Therapeutics share for Mar 2027.
In Mar, the Positive dynamics for Esperion Therapeutics, Inc. shares will prevail with possible monthly volatility of 14.547% volatility is expected.
Pessimistic target level: 5.65
Optimistic target level: 6.61
Target values for the price of one Esperion Therapeutics share for Apr 2027.
In Apr, the Positive dynamics for Esperion Therapeutics, Inc. shares will prevail with possible monthly volatility of 22.707% volatility is expected.
Pessimistic target level: 5.85
Optimistic target level: 7.57
Target values for the price of one Esperion Therapeutics share for May 2027.
In May, the Negative dynamics for Esperion Therapeutics, Inc. shares will prevail with possible monthly volatility of 25.466% volatility is expected.
Pessimistic target level: 4.95
Optimistic target level: 6.64
Target values for the price of one Esperion Therapeutics share for Jun 2027.
In Jun, the Positive dynamics for Esperion Therapeutics, Inc. shares will prevail with possible monthly volatility of 32.116% volatility is expected.
Pessimistic target level: 6.05
Optimistic target level: 8.91
Target values for the price of one Esperion Therapeutics share for Jul 2027.
In Jul, the Positive dynamics for Esperion Therapeutics, Inc. shares will prevail with possible monthly volatility of 28.547% volatility is expected.
Pessimistic target level: 7.39
Optimistic target level: 10.35
Target values for the price of one Esperion Therapeutics share for Aug 2027.
In Aug, the Negative dynamics for Esperion Therapeutics, Inc. shares will prevail with possible monthly volatility of 24.721% volatility is expected.
Pessimistic target level: 7.23
Optimistic target level: 9.60
Target values for the price of one Esperion Therapeutics share for Sep 2027.
In Sep, the Negative dynamics for Esperion Therapeutics, Inc. shares will prevail with possible monthly volatility of 20.377% volatility is expected.
Pessimistic target level: 6.27
Optimistic target level: 7.87
Target values for the price of one Esperion Therapeutics share for Oct 2027.
In Oct, the Negative dynamics for Esperion Therapeutics, Inc. shares will prevail with possible monthly volatility of 30.363% volatility is expected.
Pessimistic target level: 5.56
Optimistic target level: 7.99
Target values for the price of one Esperion Therapeutics share for Nov 2027.
In Nov, the Positive dynamics for Esperion Therapeutics, Inc. shares will prevail with possible monthly volatility of 19.183% volatility is expected.
Pessimistic target level: 6.65
Optimistic target level: 8.23
Target values for the price of one Esperion Therapeutics share for Dec 2027.
In Dec, the Positive dynamics for Esperion Therapeutics, Inc. shares will prevail with possible monthly volatility of 25.520% volatility is expected.
Pessimistic target level: 6.75
Optimistic target level: 9.06
Related stocks from Healthcare sector
